Price
No data yet.
Social Signal Score
Analyst Ratings
28 analystsRevenue
$1.35B+31.15%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Chrishan Anthon Sebastian Villavarayan
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Employees
- 12,200
- Beta
- 1.24
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 2.34
Financials
Revenue
$1.35B+31.2%Net Income
$89.00MEBITDA
$171.00M+53.8%Free Cash Flow
$104.00M-5.5%EPS (diluted)
$0.41Shares Outstanding (diluted)
214.70M-10.0%Operating Expenses
$231.00MCash & Debt
$633.00MReturn of Capital
$0.00Revenue by Segment (annual)
$5.12BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.12B | $378.00M | $1.75 |
| 2024 | $5.28B | $391.00M | $1.78 |
| 2023 | $5.18B | $267.00M | $1.21 |
| 2022 | $4.88B | $192.00M | $0.87 |
| 2021 | $4.42B | $263.90M | $1.14 |
| 2020 | $3.74B | $121.60M | $0.52 |
| 2019 | $4.48B | $249.00M | $1.06 |
| 2018 | $4.70B | $207.10M | $0.87 |
| 2017 | $4.38B | $36.70M | $0.15 |
| 2016 | $4.09B | $38.80M | $0.18 |
| 2015 | $4.11B | $91.60M | $0.40 |
| 2014 | $4.39B | $27.40M | $0.12 |
| 2013 | $3.99B | $-224.90M | $-0.99 |
| 2012 | $4.26B | $243.30M | $1.06 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from AXTA's reported EPS growth of 3.9% a year over 13 years.
- EPS in 5 years
- $2.12
- Implied price
- $38.14
- Return from $32.68
- 3.1% a year
To earn 15.0% a year on these assumptions you'd need to buy at $18.96 — -42.0% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -6.1% | -14.0% | -10.1% | -6.8% | -3.9% | -1.3% |
| -1.1% | -9.5% | -5.3% | -1.8% | 1.2% | 4.0% |
| 3.9% | -4.9% | -0.6% | 3.1% | 6.4% | 9.2% |
| 8.9% | -0.3% | 4.2% | 8.1% | 11.5% | 14.5% |
| 13.9% | 4.3% | 9.0% | 13.1% | 16.6% | 19.8% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50+0.00%Social Signal Score
Mentions (9)
- Newsglobenewswire.com·1d ago·Neutral
Axalta Schedules Third Quarter 2026 Earnings Conference Call PHILADELPHIA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Axalta Coating Systems (NYSE: AXTA), a leading global coatings company, will release its third quarter 2026 financial results at 6 a.m. ET on Thursday, October 29, 2026. The release and supporting materials will be posted to Axalta's Investor Relations site .
View source ↗ - News (RSS)ft·1d ago·Negative
AkzoNobel nears deal to sell its SE Asia decorative paint unit to Nippon Paint Dutch group on verge of handing Japanese rival a small victory as it seeks to exit non-core markets ahead of Axalta merger
View source ↗ - Newszacks.com·3d ago·Neutral
Bears are Losing Control Over Axalta Coating Systems (AXTA), Here's Why It's a 'Buy' Now After losing some value lately, a hammer chart pattern has been formed for Axalta Coating Systems (AXTA), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
View source ↗ - Newszacks.com·6d ago·Neutral
AXTA or HWKN: Which Is the Better Value Stock Right Now? Investors interested in Chemical - Specialty stocks are likely familiar with Axalta Coating Systems (AXTA) and Hawkins (HWKN). But which of these two stocks is more attractive to value investors?
View source ↗ - Newszacks.com·24d ago·Positive
AXTA vs. HWKN: Which Stock Is the Better Value Option? Investors interested in Chemical - Specialty stocks are likely familiar with Axalta Coating Systems (AXTA) and Hawkins (HWKN). But which of these two companies is the best option for those looking for undervalued stocks?
View source ↗ - News (RSS)seekingalpha·27d ago·Negative
Axalta: Selling Body-Shop Productivity At A Materials Multiple
View source ↗ - Newsseekingalpha.com·27d ago·Negative
…y At A Materials Multiple Axalta Coating Systems is leveraging digital color management and operational efficiency to compete on repair cost, not just paint pricing. AXTA's Q2 2026 results show margin expansion and deleveraging, but volume recovery remains muted and headline growth is aided by price/mix and acquisitions. The pending AkzoNobel merger offers $600M in targeted synergies, but value creation hinges on execution, integration, and sustaining customer productivity advantages.
View source ↗ - Newszacks.com·40d ago·Positive
AXTA vs. HWKN: Which Stock Should Value Investors Buy Now? Investors interested in stocks from the Chemical - Specialty sector have probably already heard of Axalta Coating Systems (AXTA) and Hawkins (HWKN). But which of these two stocks presents investors with the better value opportunity right now?
View source ↗ - Newszacks.com·56d ago·Neutral
AXTA or HWKN: Which Is the Better Value Stock Right Now? Investors interested in Chemical - Specialty stocks are likely familiar with Axalta Coating Systems (AXTA) and Hawkins (HWKN). But which of these two stocks is more attractive to value investors?
View source ↗
Earnings
Tue, Oct 27(in 3 weeks)
Consensus estimate $0.71 per share
Typical surprise +9.3% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Jul 28$0.72 vs $0.65beat
- Thu, Apr 30$0.56 vs $0.50beat
- Tue, Feb 10$0.59 vs $0.60miss
- Tue, Oct 28$0.67 vs $0.64beat
- Wed, Jul 30$0.64 vs $0.61beat
- Wed, May 7$0.59 vs $0.54beat
Estimates and results for AXTA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by AXTA officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Jun 11, 2026 (16d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 11, 2026 (15d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (17d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (16d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 12, 2025 (21d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 12, 2025 (21d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 12, 2025 (30d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Dec 6, 2024 (24d later)Sell$1,001 - $15,000
- John Jameshouse · MI10 · disclosed Sep 2, 2024 (119d later)Sell$1,001 - $15,000
- John Jameshouse · MI10 · disclosed Sep 2, 2024 (297d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (28d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 6, 2023 (36d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 6, 2023 (36d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 7, 2023 (17d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 7, 2023 (20d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 7, 2023 (10d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 7, 2023 (26d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 7, 2023 (19d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 7, 2023 (26d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 7, 2023 (17d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.